Max BioPharma

Santa Monica, United States

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

$13.0M raised

Mar 2026

Series A

Biopharma Biotechnology Health Care

Top Investors

Technomark Life Sciences

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Max BioPharma

How much funding has Max BioPharma raised?

Max BioPharma has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are Max BioPharma's investors?

Max BioPharma's investors include Technomark Life Sciences.

Where is Max BioPharma headquartered?

Max BioPharma is headquartered in Santa Monica, United States.

What does Max BioPharma do?

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

What stage is Max BioPharma at?

Max BioPharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2026.

MLA

"Max BioPharma — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/max-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2026). Max BioPharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/max-biopharma

Wikipedia (cite web)

{{cite web |title=Max BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/max-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.